NCT06236464 Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
| NCT ID | NCT06236464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Naples |
| Condition | Squamous Cell Carcinoma of the Head and Neck |
| Study Type | OBSERVATIONAL |
| Enrollment | 170 participants |
| Start Date | 2023-09-25 |
| Primary Completion | 2025-11-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 170 participants in total. It began in 2023-09-25 with a primary completion date of 2025-11-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multicentric, retrospective, and prospective biomarker study.
Eligibility Criteria
Inclusion Criteria: Patients aged ≥ 18 years, candidates for surgical treatment for squamous cell carcinoma of the anus, uterine cervix, vulva, and head-neck region (including microinvasive and invasive carcinomas) who are capable of understanding and willing to sign the informed consent form. Prospective patients must provide written informed consent before any procedures. Exclusion Criteria: Patients presenting any of the following criteria are not eligible for inclusion in this study. Exclusion criteria include: 1. Metastatic neoplasia 2. Treatment for other oncological pathologies 3. Congenital or acquired immunosuppression (HIV, organ transplant, pharmacological)
Contact & Investigator
Maria Lina Tornesello, M.D.
PRINCIPAL INVESTIGATOR
IRCCS I.N.T. "G. Pascale"
Frequently Asked Questions
Who can join the NCT06236464 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Squamous Cell Carcinoma of the Head and Neck. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06236464 currently recruiting?
Yes, NCT06236464 is actively recruiting participants. Contact the research team at m.tornesello@istitutotumori.na.it for enrollment information.
Where is the NCT06236464 trial being conducted?
This trial is being conducted at Bari, Italy, Naples, Italy, Novara, Italy, Pisa, Italy.
Who is sponsoring the NCT06236464 clinical trial?
NCT06236464 is sponsored by National Cancer Institute, Naples. The principal investigator is Maria Lina Tornesello, M.D. at IRCCS I.N.T. "G. Pascale". The trial plans to enroll 170 participants.